News about Industrial talks

China's NMPA Approves Sanofi-Licensed Myqorzo and Redemplo for Rare Cardiac and Lipid Disorders

Myqorzo and Redemplo approvals by NMPA expand treatment options for obstructive hypertrophic cardiomyopathy and familial chylomicronaemia syndrome in adult patients across Greater China.

Industrial talks | 17/01/2026 | By News Bureau |  344

AbbVie Aligns Drug Development and Manufacturing Plans for Obesity Portfolio

AbbVie is moving to establish a strong presence in the obesity treatment market, with a strategy that emphasizes manufacturing scalability, supply readiness, and long-term production efficiency alongside clinical development.

Industrial talks | 16/01/2026 | By Darshana |  158

Innovation Led Growth Dominates Indian Pharma Market in 2025

The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.

Industrial talks | 15/01/2026 | By News Bureau |  1205

Eisai, Nuvation Bio Collaborates to Expand Taletrectinib's Global Reach

The collaboration between Eisai and Nuvation to expand global development and commercialisation of taletrectinib for ROS1-positive non-small cell lung cancer.

Industrial talks | 15/01/2026 | By News Bureau |  268

Oricell Therapeutics Raises USD 70M in Series C1 to Advance CAR-T Therapies for Solid Tumors

The funding will accelerate global expansion and clinical development of Oricell’s CAR-T pipeline, including its lead hepatocellular carcinoma programme Ori-C101.

Industrial talks | 13/01/2026 | By News Bureau |  272

ChemWerth Appoints General Sales Manager to Expand API Presence in India

ChemWerth has appointed industry veteran Chandrakanth Reddy as General Sales Manager to drive growth in its generic API business in India, drawing on his 16+ years of experience across multiple global markets.

Industrial talks | 13/01/2026 | By News Bureau |  120

23rd BioAsia to be Held from 16 to 18 Feb in Hyderabad

The Telangana government has launched BioAsia 2026, highlighting the summit’s focus on TechBio, AI and automation as key drivers reshaping life sciences, healthcare innovation and global health systems.

Industrial talks | 12/01/2026 | By News Bureau |  183

WHO Updates HIV Treatment and TB Prevention Guidelines

New WHO recommendations strengthen antiretroviral therapy choices, vertical HIV transmission management and TB preventive treatment to improve outcomes and accelerate progress toward ending AIDS globally.

Industrial talks | 08/01/2026 | By News Bureau |  268

Bayer's Monsanto Unit Sues Major COVID Vaccine Makers Over mRNA Patent Infringement

German chemical and life sciences company Bayer, through its Monsanto subsidiary, has filed a series of patent infringement lawsuits against several major COVID-19 vaccine manufacturers, alleging unauthorised use of its messenger RNA (mRNA) technology in the development of coronavirus vaccines.

Industrial talks | 07/01/2026 | By Darshana |  169

PHARMEXCIL Engages Government Leaders to Strengthen Indian Pharmaceutical Export Growth

The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level discussions with key government stakeholders to align policy priorities, accelerate export momentum and reinforce India’s position in global pharmaceutical markets.

Industrial talks | 06/01/2026 | By News Bureau |  356